Mon, Apr 14, 5:31 PM (33 days ago)
**Stimcell Energetics Inc. (STCE) Q1 2025 Financial Summary** Stimcell Energetics Inc. (STCE), formerly Cell MedX Corp., reported its Q1 2025 financial results, highlighting a challenging quarter marked by significant operational expenses and financial uncertainties. The company, focused on biotech and wellness products, faced substantial financial hurdles despite strategic initiatives. **Financial Performance:** - **Revenue:** STCE reported no revenue for the quarter, consistent with previous periods. - **Operating Expenses:** Total operating expenses surged by 126.9% to $131,086, driven by increased foreign exchange losses ($41,552) and management fees ($22,500). - **Net Loss:** The company incurred a net loss of $140,537, a significant increase from the previous year's net income of $119,971, primarily due to higher operating expenses and lower non-operating income. - **Cash Flow:** STCE used $83,152 in cash for operations, financed partly by borrowing $46,745 from related parties. - **Liquidity:** As of February 28, 2025, STCE had a cash balance of $6,678 and a working capital deficit of $1,070,215. **Key Metrics and Trends:** - **Profit Margins:** The company operates at a significant loss, with negative profit margins across all metrics. - **Cash Flow:** Negative cash flow from operations indicates liquidity challenges. - **Earnings Changes:** The net loss increased dramatically due to higher expenses and lower non-operating income. **Strategic Initiatives and Future Operations:** - **Partnerships:** STCE announced a partnership with ADM Tronics to redesign its eBalance® microcurrent device for home use. - **Marketing Agreement:** The company entered into a digital marketing services agreement with Rain Communications to enhance brand awareness. - **Debt Settlement:** STCE settled $15,000 in outstanding debt through the issuance of 75,000 shares. **Uncertainties and Risks:** - **Going Concern:** STCE faces substantial doubt about its ability to continue as a going concern due to financial difficulties and the need for additional financing. - **Market Risks:** The company operates in a highly competitive market with significant regulatory and intellectual property challenges. - **Operational Risks:** Dependence on related-party financing and the need for substantial capital expenditures pose risks to future operations. **Conclusion:** STCE's Q1 2025 results reflect ongoing financial challenges, with significant operating losses and liquidity concerns. The company's strategic initiatives, including partnerships and marketing efforts, aim to address these issues. However, the ability to secure additional financing and achieve profitable operations remains critical for STCE's future sustainability. Investors should closely monitor the company's progress in securing financing and executing its strategic plans.